1. Home
  2. BRSP vs AURA Comparison

BRSP vs AURA Comparison

Compare BRSP & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightSpire Capital Inc.

BRSP

BrightSpire Capital Inc.

HOLD

Current Price

$5.10

Market Cap

738.7M

Sector

Real Estate

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.90

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRSP
AURA
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.7M
713.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
BRSP
AURA
Price
$5.10
$7.90
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.50
$20.00
AVG Volume (30 Days)
1.5M
375.1K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
11.03%
N/A
EPS Growth
75.24
N/A
EPS
N/A
N/A
Revenue
$330,587,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.85
$4.73
52 Week High
$6.17
$9.54

Technical Indicators

Market Signals
Indicator
BRSP
AURA
Relative Strength Index (RSI) 42.99 66.12
Support Level $4.85 $6.65
Resistance Level $5.52 $7.83
Average True Range (ATR) 0.14 0.26
MACD 0.00 0.09
Stochastic Oscillator 44.07 85.42

Price Performance

Historical Comparison
BRSP
AURA

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: